BACKGROUND: Recent evidence suggests patients bridged to heart transplant (BTT) have equivalent outcomes as those undergoing conventional orthotopic heart transplantation (OHT). However, data on risk factors for early death in BTT patients are limited. METHODS: We retrospectively reviewed the United Network for Organ Sharing database of all patients bridged to OHT with a HeartMate II from January 2005 to December 2010. The primary outcome was all-cause 90-day mortality. Additional postoperative outcomes were cerebrovascular accident and need for renal replacement therapy. Kaplan-Meier analysis assessed survival. Preoperative variables associated with 90-day death on univariate analysis (p<0.2) were included in a multivariable Cox proportional hazards regression. RESULTS: A HeartMate II was used to bridge 1,312 patients (average age, 52±12 years) to OHT, most commonly for idiopathic cardiomyopathy (50.7%). During the study, 171 patients (13.0%) died. The unadjusted 90-day survival was 92.3%. The highest annual average center volume in this cohort, examining for BTT recipients only, was 28 BTT procedures yearly. Postoperative cerebrovascular accident occurred in 29 patients (2.2%), and 106 (8.3%) required renal replacement therapy. Cox regression revealed age, glomerular filtration rate, African American race, human leukocyte antigen mismatch, serum bilirubin, need for mechanical ventilation, donor age, and prolonged ischemia time were associated with 90-day death. Early survival was improved for patients who underwent OHT at high-volume centers (p=0.01). CONCLUSIONS: This study examining risk factors for early death in patients bridged to OHT using HeartMate II mechanical assistance will aid in identifying patients best suited to benefit from this technology.
BACKGROUND: Recent evidence suggests patients bridged to heart transplant (BTT) have equivalent outcomes as those undergoing conventional orthotopic heart transplantation (OHT). However, data on risk factors for early death in BTTpatients are limited. METHODS: We retrospectively reviewed the United Network for Organ Sharing database of all patients bridged to OHT with a HeartMate II from January 2005 to December 2010. The primary outcome was all-cause 90-day mortality. Additional postoperative outcomes were cerebrovascular accident and need for renal replacement therapy. Kaplan-Meier analysis assessed survival. Preoperative variables associated with 90-day death on univariate analysis (p<0.2) were included in a multivariable Cox proportional hazards regression. RESULTS: A HeartMate II was used to bridge 1,312 patients (average age, 52±12 years) to OHT, most commonly for idiopathic cardiomyopathy (50.7%). During the study, 171 patients (13.0%) died. The unadjusted 90-day survival was 92.3%. The highest annual average center volume in this cohort, examining for BTT recipients only, was 28 BTT procedures yearly. Postoperative cerebrovascular accident occurred in 29 patients (2.2%), and 106 (8.3%) required renal replacement therapy. Cox regression revealed age, glomerular filtration rate, African American race, human leukocyte antigen mismatch, serum bilirubin, need for mechanical ventilation, donor age, and prolonged ischemia time were associated with 90-day death. Early survival was improved for patients who underwent OHT at high-volume centers (p=0.01). CONCLUSIONS: This study examining risk factors for early death in patients bridged to OHT using HeartMate II mechanical assistance will aid in identifying patients best suited to benefit from this technology.
Authors: George J Arnaoutakis; Timothy J George; Arman Kilic; Eric S Weiss; Stuart D Russell; John V Conte; Ashish S Shah Journal: J Thorac Cardiovasc Surg Date: 2011-08-11 Impact factor: 5.209
Authors: Stavros G Drakos; Abdallah G Kfoury; James W Long; James C Stringham; Edward M Gilbert; Stephanie A Moore; Beverly K Campbell; Karl E Nelson; Benjamin D Horne; Dale G Renlund Journal: J Heart Lung Transplant Date: 2005-11-02 Impact factor: 10.247
Authors: Eric S Weiss; Robert A Meguid; Nishant D Patel; Stuart D Russell; Ashish S Shah; William A Baumgartner; John V Conte Journal: Ann Thorac Surg Date: 2008-10 Impact factor: 4.330
Authors: David O Taylor; Leah B Edwards; Paul Aurora; Jason D Christie; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Anna Y Kucheryavaya; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2008-09 Impact factor: 10.247
Authors: Mark J Russo; Kimberly N Hong; Ryan R Davies; Jonathan M Chen; Robert A Sorabella; Deborah D Ascheim; Mathew R Williams; Annetine C Gelijns; Allan S Stewart; Michael Argenziano; Yoshifumi Naka Journal: J Thorac Cardiovasc Surg Date: 2009-12 Impact factor: 5.209
Authors: C J Taylor; S I Smith; L D Sharples; J Parameshwar; N R Cary; M Keogan; J Wallwork; S R Large Journal: Transplantation Date: 1997-05-15 Impact factor: 4.939
Authors: Vishnu Patlolla; Richard D Patten; David Denofrio; Marvin A Konstam; Rajan Krishnamani Journal: J Am Coll Cardiol Date: 2009-01-20 Impact factor: 24.094
Authors: Lois U Nwakanma; Jason A Williams; Eric S Weiss; Stuart D Russell; William A Baumgartner; John V Conte Journal: Ann Thorac Surg Date: 2007-11 Impact factor: 4.330
Authors: George J Arnaoutakis; Azra Bihorac; Tomas D Martin; Philip J Hess; Charles T Klodell; A Ahsan Ejaz; Cyndi Garvan; Curtis G Tribble; Thomas M Beaver Journal: J Thorac Cardiovasc Surg Date: 2007-10-29 Impact factor: 5.209
Authors: Jay D Pal; Valentino Piacentino; Angela D Cuevas; Tim Depp; Mani A Daneshmand; Adrian F Hernandez; G Michael Felker; Andrew J Lodge; Joseph G Rogers; Carmelo A Milano Journal: Ann Thorac Surg Date: 2009-11 Impact factor: 4.330
Authors: Nicholas A Haglund; Irene D Feurer; Rashid M Ahmad; Thomas G DiSalvo; Daniel J Lenihan; Mary E Keebler; Kelly H Schlendorf; John M Stulak; Mark A Wigger; Simon Maltais Journal: J Heart Lung Transplant Date: 2014-05-15 Impact factor: 10.247
Authors: Shuichi Kitada; P Christian Schulze; Zhezhen Jin; Kevin Clerkin; Shunichi Homma; Donna M Mancini Journal: Int J Cardiol Date: 2015-11-09 Impact factor: 4.164